The National Milk Producers Federation is urging the FDA to enforce its existing rules against mislabeling plant-based products with dairy terms, citing widespread consumer confusion over the nutritional content of dairy-product imitators.
“Clear, accurate labeling is a fundamental matter of truth and transparency for consumers,” NMPF said in comments filed with the agency today. The comments present evidence of rampant marketplace confusion regarding the relative nutritional merits of milk versus its imitators.
In rules revised in April 2018, the FDA defines milk and cheese as coming from a lacteal secretion, and as such, could not be derived from a plant.
According to NMPF surveys from the past six months:
- 77 percent of buyers of dairy and plant-based beverages think almond-based drinks have as much or more protein than dairy, when in fact real milk has as much as eight times more protein;
- 78 percent thought plant-based beverages had at least as many vitamins and minerals as dairy, again incorrect;
- 68 percent thought such beverages had at least as many “key nutrients” such as calcium and potassium, which they do not; and
- While consumer confusion over nutrition is a key NMPF concern, research funded by plant-based beverage supporters found more basic confusion: Roughly 25 percent of consumers were unsure whether plant-based beverages contained cow’s milk.
Reliance on non-dairy imitators for dairy-quality nutrition in products including milk, cheese, yogurt and butter has an effect on public health, as FDA Commissioner Scott Gottlieb said last year when he pledged to address the issue. Medical reports of protein malnutrition and Vitamin D deficiency in children have been linked to plant-based beverage consumption. Meanwhile, surveys show that only 20 percent of all consumers believe plant-based drinks should be labeled milk.
“The science is clear. The consumer need is clear. And consumer sentiment is clear: FDA needs to step up and enforce its standard of identity for dairy terms on food labels,” said Jim Mulhern, president and CEO of NMPF. “We urge FDA to do what’s right for public health and marketplace integrity.”
For more information and links to recent surveys, visit www.nmpf.org.
